I follow an underground, counter-culture type medical blog called Medicynic. Always good to get a different perspective, right? Here is a link to a story I read there today: Why We Need Comparative Medical Studies: Zometa.
The short post features several links back to reputable articles about how Zometa “did not appear to prevent breast cancer from returning or to boost disease-free survival overall.”
Why this is important for a bisphosphonate–I thought Zometa showing promise in slowing-down multiple myeloma was just a bonus–to extend disease-free survival.
But the story was important enough to be featured on WebMD and Bloomberg Business News.
Tired of ASH news yet? I hope not! After giving you (and me!) a short break, I will be featuring a new ASH related article every day starting Monday for the next week or two. I will also share a multi-part expose’ I am writing about the medical equipment industry.
Feel good and keep smiling! Pat